Press Releases
What's Rad 140?

, 10 August 2018 -- Testolone (RAD140) is a selective androgen receptor modulator (SARM) being developed by the pharmaceutical company Radius for the treatment of breast cancer and muscle wasting in postmenopausal women. Testolone is very new to the commercial market with its initial discovery in 2010. The initial studies, company reports, and anecdotal user reviews have been highly promising for the muscle building properties of RAD 140.

In the at present readily available SARMs, RAD 140 is definitely the most lately created. Should you be new towards the world of SARMs, you could possibly have realized that a lot of tend to have unusual names consisting of a series of letters and numbers. These analysis chemical substances haven't been authorized for official use in the medical field. This is the reason they may be still being identified by abbreviations of their respective developers’ names. RAD 140 is currently being created by a corporation referred to as Radius Health, which explains the “RAD” portion with the name. Several of those compounds also have unofficial names that sound comparable towards the names of steroids - as an illustration, just as RAD 140 can also be known as testolone, LGD-4033 is called ligandrol. Get more details about <a href=""></a

Non-steroidal SARMs have been about for decades (and steroidal SARMs even longer). This supplement was announced to the study planet in 2010, making it very new in comparison to a few of the significantly older SARMs. For the reason that of its common newness, you will discover far fewer studies on it than have been accomplished on older SARMs, like the well known ostarine. Ostarine and older SARMs have been tested somewhat extensively on humans. Most RAD 140 studies happen to be performed on animals, however the final results are nevertheless promising. Further animal study is likely to cause clinical studies in humans, which in turn will deliver the bodybuilding neighborhood with beneficial details concerning dosage as well as other variables.

Whilst considerably of your common research on SARMs focuses on their mechanism of action and on their effects as a complete, skilled SARM users have noted that unique SARMs have slight rewards in particular places. For instance, ostarine is normally generally known as getting particularly valuable as a cutting and recomp drug. Ligandrol (also named LGD 4033) is well-suited to bulking.

There's much less of a common consensus on RAD 140, just because this is such a brand new supplement. But using a 90:1 anabolic to androgenic ratio, it has the possible to make muscle development comparable to testosterone. Some users have noted that RAD 140 appears to enhance speed and endurance as well. This supplement shows possible as an all-around efficiency enhancer also as the prospective for creating muscle.

# # #

Submitted by Kyle Crum on Friday, 10 August 2018 at 2:53 PM
Category: Health Care & Medical
Related News

Breath Analyzers Market to Attain a Value of USD 4,518.4 Million by 2019
Friday, 18 Jan 2019

Elderly and Disabled Assistive Devices Market to Become Worth USD 19,684.9 Million by 2019
Friday, 18 Jan 2019

Cleanroom Consumables Market - Advent of Nanotechnology to Boost Market Growth
Friday, 18 Jan 2019

Telehealth Market - Increase in Applications of Telehealth to Boost the Market
Friday, 18 Jan 2019

Advanced Wound Care Management Market - Need for Treatment of Complex Wounds to Propel the Market
Thursday, 17 Jan 2019

Related Events

11th Annual ICJR Winter Hip and Knee Course, Vail 2019
Thursday, 17 Jan 2019

9th Annual Orthopaedic Trauma and Fracture Care: Pushing the Envelope
Thursday, 17 Jan 2019

Breast Ultrasound CME Course with Tom Stavros, San Antonio 2019
Friday, 18 Jan 2019

Maternal-Fetal Imaging CME Course Advances in OB-GYN Ultrasound 2019
Friday, 18 Jan 2019

2nd Tri-Regional Meeting - A New smile for Africa, Jan 2019, Kenya
Friday, 18 Jan 2019

Latest News

Bignaija Offers a Dynamic Platform to All the Lovers of Nigerian and Foreign Music
Friday, 18 Jan 2019

Functional Oligosaccharides Market – Overview of Vital Industry Drivers
Friday, 18 Jan 2019

What to understand Having a Towing Service
Friday, 18 Jan 2019

Why To Play Online Poker
Friday, 18 Jan 2019

Breath Analyzers Market to Attain a Value of USD 4,518.4 Million by 2019
Friday, 18 Jan 2019

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Friday, 18 January 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Property Deal Network Leeds - Property Investor Meet up
  • 11th Annual ICJR Winter Hip and Knee Course, Vail 2019
  • Palo Alto Networks: GO FAST, STAY SECURE - Security for Public Clouds
  • 9th Annual Orthopaedic Trauma and Fracture Care: Pushing the Envelope
  • Breast Ultrasound CME Course with Tom Stavros, San Antonio 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.